ENST00000379989.6:c.2984T>G
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 2P and 10B. PM2BP4_ModerateBP6_Very_Strong
The ENST00000379989.6(CDKL5):c.2984T>G(p.Phe995Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. F995I) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000379989.6 missense
Scores
Clinical Significance
Conservation
Publications
- retinoschisisInheritance: XL Classification: DEFINITIVE Submitted by: G2P
- X-linked retinoschisisInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RS1 | NM_000330.4 | c.184+3218A>C | intron_variant | Intron 3 of 5 | ENST00000379984.4 | NP_000321.1 | ||
| CDKL5 | NM_001037343.2 | c.2984T>G | p.Phe995Cys | missense_variant | Exon 22 of 22 | NP_001032420.1 | ||
| CDKL5 | NM_003159.3 | c.2984T>G | p.Phe995Cys | missense_variant | Exon 21 of 21 | NP_003150.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CDKL5 | ENST00000379989.6 | c.2984T>G | p.Phe995Cys | missense_variant | Exon 22 of 22 | 1 | ENSP00000369325.3 | |||
| CDKL5 | ENST00000379996.7 | c.2984T>G | p.Phe995Cys | missense_variant | Exon 21 of 21 | 1 | ENSP00000369332.3 | |||
| RS1 | ENST00000379984.4 | c.184+3218A>C | intron_variant | Intron 3 of 5 | 1 | NM_000330.4 | ENSP00000369320.3 | |||
| CDKL5 | ENST00000673617.1 | n.256T>G | non_coding_transcript_exon_variant | Exon 3 of 3 |
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD2 exomes AF: 0.0000111 AC: 2AN: 180978 AF XY: 0.0000305 show subpopulations
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000547 AC: 6AN: 1097474Hom.: 0 Cov.: 31 AF XY: 0.0000165 AC XY: 6AN XY: 362914 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 24
ClinVar
Submissions by phenotype
not specified Benign:1
In exon 20, affecting only the transcript lowly expressed; In silico prediction: SIFT = tolerated, MutationTaster = polymorphism, PolyPhen2 = benign, AlignGVGD = benign (C0) -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
CDKL5 disorder Benign:1
This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as likely benign. At least the following criteria are met: The allele frequency of this variant in at least one population in gnomAD is between 0.008% and 0.03% (BS1). Computational prediction analysis tools suggest no impact on gene product (REVEL score <= 0.15), The computational splicing predictor SpliceAI does not support significant splicing alteration (score of <=0.1) (BP4). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at